Gsk2656157
| CAS No. | 1337532-29-2 |
|---|---|
| MDL No. | MFCD27997885 |
| MF | C23H21FN6O |
| MW | 416.50 |
| InChI Key | PRWSIEBRGXYXAJ-UHFFFAOYSA-N |
| CAS No. | 1337532-29-2 |
|---|---|
| MDL No. | MFCD27997885 |
| MF | C23H21FN6O |
| MW | 416.50 |
| InChI Key | PRWSIEBRGXYXAJ-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
GSK2656157 is a pyrrolopyrimidine, specifically 7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine, substituted at position 5 with a 4-fluoro-2,3-dihydro-1H-indol-5-yl group, whose nitrogen is acylated by a (6-methylpyridin-2-yl)acetyl group. It is an orally bioavailable PERK inhibitor with activity as a protein-tyrosine-phosphatase inhibitor and an antineoplastic agent. It belongs to the classes of biaryl, indole, methylpyridine, organofluorine, and tertiary carboxamide compounds.
| CAS No. | 1337532-29-2 |
|---|---|
| Product Name | Gsk2656157 |
| Heavy Atom Count | 31 | Rotatable Bond Count | 3 |
| Atom Stereo Count | 0 | Bond Stereo Count | 0 |
| HBA | 6 | HBD | 1 |
| TPSA | 89.930 Ų | Charge | 0 |
| Exact Mass | 416.17609 | Complexity | 1345.65 |
| pKa | 7.130 | XLogP | 3.192 |